| Boundary tracing |
Mohsen Rezapour |
The University of Texas, Health Science center at Houston |
PLCO |
Mar 9, 2021 |
PLCO-699 |
| Non-Genetic Risk Factors for Endometrial Cancer |
Surabhi Sajith |
BASIS Ahwatukee |
PLCO |
Mar 9, 2021 |
PLCO-743 |
| Association of Adulthood Weight Change with Lung Cancer Risk and Mortality |
Hyung-Suk Yoon |
Vanderbilt University Medical Center |
PLCO |
Feb 22, 2021 |
PLCO-738 |
| Detecting Medical Errors in the Cancer Screening Process: An In-Depth Review of Lung Cancer Screening & at Risk Qualifications |
Brianna Johnson |
University of Massachusetts Dartmouth |
PLCO |
Feb 22, 2021 |
PLCO-737 |
| Adding metabolite names from PLCO, ATBC studies to COMETS metabolite dictionary |
Steven Moore |
National Cancer Institute |
PLCO |
Feb 3, 2021 |
PLCO-733 |
| Novel Dietary Index for Gut Microbiota and Associations with Colorectal Cancer and Breast Cancer Risk |
Susan Steck |
University of South Carolina |
PLCO |
Jan 28, 2021 |
PLCO-730 |
| Time to Event Prediction Based on Risk Calculation from Biomarkers |
Anna Lokshin |
University of Pittsburgh |
PLCO |
Jan 28, 2021 |
PLCO-717 |
| Develop a Markovian-based natural history model for ovarian cancer progression |
Andrew Schaefer |
Rice University |
PLCO |
Jan 28, 2021 |
PLCO-729 |
| Impact of Anti-Inflammatory Medication Use on Breast Cancer Incidence and Survival in Elderly ER+ Breast Cancer |
Adrian Lee |
University of Pittsburgh Medical Center |
PLCO |
Jan 28, 2021 |
PLCO-725 |
| Explainable Machine Learning for Personalized Decision-Making in Prostate Cancer |
Krithika Suresh |
University of Colorado |
PLCO |
Jan 28, 2021 |
PLCO-726 |
| Predicting Late Stage Cancer |
Paul Pinsky |
NCI |
PLCO |
Jan 25, 2021 |
PLCO-727 |
| Development of cell-free DNA (cfDNA) 5-hydroxymethylcytosine (5hmC) biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) |
Marc Bissonnette |
University of Chicago |
PLCO |
Jan 15, 2021 |
2020-1003 |
| Association between socioeconomic status and colorectal cancer survival in patients participating in the PLCO cancer screening trial |
Laura Davis |
Independent |
PLCO |
Jan 14, 2021 |
PLCO-714 |
| The impact of body mass index (BMI) on cancer screening |
Sonja Berndt |
National Cancer Institute |
PLCO |
Jan 14, 2021 |
PLCO-716 |
| Prospective metabolomics study of gastric cancer |
Xiang Shu |
Memorial Sloan Kettering Cancer Center |
PLCO |
Jan 13, 2021 |
2020-1017 |
| Generalizing the effect of chest x-ray screening |
Jon Steingrimsson |
Brown University |
PLCO |
Dec 31, 2020 |
PLCO-707 |
| Implication of new models for predicting lung cancer screening selection based on CT scan and pathology image data |
Yuan Luo |
Northwestern University |
PLCO |
Dec 31, 2020 |
PLCO-710 |
| Automated Medical Diagnostic Systems |
Fabien Scalzo |
University of California, Los Angeles (UCLA) |
PLCO |
Dec 29, 2020 |
PLCO-711 |
| Development of improved pre-diagnostic biomarker-based screening algorithms for ovarian cancer |
Anna Lokshin |
UPMC Hillman Cancer Center |
PLCO |
Dec 22, 2020 |
2020-1020 |
| Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States. |
Haejin In |
Rutgers Cancer Institute |
PLCO |
Dec 22, 2020 |
2020-1002 |
